Diagnostics
Total Trials
26
As Lead Sponsor
14
As Collaborator
12
Total Enrollment
15,541
NCT01833195
Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing
Phase: N/A
Role: Lead Sponsor
Start: Mar 31, 2013
Completion: Feb 29, 2020
NCT02178943
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
Start: Jun 30, 2014
NCT02424227
Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation
Start: Apr 30, 2015
Completion: Jan 31, 2019
NCT04271267
Cell-free DNA as a Biomarker After Lung Transplantation
Role: Collaborator
Start: Dec 20, 2015
Completion: Nov 30, 2019
NCT03326076
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Start: Jan 23, 2018
Completion: Dec 31, 2025
NCT03695601
Surveillance HeartCare® Outcomes Registry
Start: Dec 28, 2018
Completion: Nov 30, 2026
NCT04566055
Assessing AlloSure Dd-cfDNA Monitoring Insights of Renal Allografts With Longitudinal Surveillance
Start: Mar 1, 2019
Completion: Oct 1, 2020
NCT04057742
AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
Start: Oct 7, 2019
Completion: Apr 7, 2024
NCT04130685
Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients
Start: Jan 15, 2020
Completion: Dec 1, 2022
NCT04177095
Immune Monitoring to Facilitate Belatacept Monotherapy
Phase: Phase 4
Start: Feb 11, 2020
Completion: Jun 1, 2023
NCT04234919
Longitudinal Study of Cell Free DNA in Lung Transplant
Start: Mar 19, 2020
Completion: Nov 22, 2021
NCT04341103
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Start: Apr 1, 2020
Completion: Mar 1, 2021
NCT04318587
Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation
Start: Jun 29, 2020
Completion: Dec 30, 2023
NCT05747053
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
Start: Oct 1, 2020
Completion: Dec 8, 2022
NCT04382248
The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
Start: Oct 15, 2020
Completion: Nov 30, 2021
NCT04601155
Transition of Renal Patients Using AlloSure Into Community Kidney Care
Start: Nov 19, 2020
Completion: Oct 6, 2023
NCT04777617
Allosure in Simultaneous Pancreas Kidney Transplant
Start: Feb 26, 2021
Completion: Jul 31, 2024
NCT04793360
Molecular Assessment and Profiling of Liver Transplant Recipients
Start: May 26, 2021
Completion: Mar 31, 2028
NCT04635384
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
Start: Jun 30, 2021
NCT04855422
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
Start: Jul 14, 2021
Completion: Dec 31, 2026
NCT04786067
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Start: Jul 28, 2021
Completion: Mar 30, 2026
NCT05060991
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
Start: Sep 24, 2021
Completion: Dec 24, 2025
NCT05033548
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Start: Oct 26, 2021
Completion: Jul 31, 2023
NCT05050955
AlloSure Lung Assessment and Metagenomics Outcomes Study
Start: Oct 29, 2021
Completion: Dec 31, 2028
NCT05423496
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
Start: Aug 31, 2022
Completion: Feb 23, 2023
NCT05459181
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
Start: Dec 31, 2025
Completion: Sep 30, 2026
Loading map...